Clinical trial
A Prospective, Randomized, Controlled, Comparitive Multicenter Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite® vs Competitor in Adult Subjects With Primary Open-Angle Glaucoma (POAG)
NCT05127551 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled, Comparitive Multicenter Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite® vs Competitor in Adult Subjects With Primary Open-Angle Glaucoma (POAG)
- Lead sponsor
- Glaukos Corporation
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 27, 2021
- Completion date
- February 28, 2025
- Enrollment
- 179 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.